{
    "id": 25026,
    "fullName": "BRAF A712T",
    "impact": "missense",
    "proteinEffect": "no effect - predicted",
    "geneVariantDescriptions": [
        {
            "description": "BRAF A712T lies within the protein kinase domain of the Braf protein (UniProt.org). A712T has not been biochemically characterized, but results in\u00a0similar cell proliferation and viability levels to wild-type Braf in culture (PMID: 29533785), and therefore is predicted to have no effect on Braf protein function.",
            "references": [
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 673,
        "geneSymbol": "BRAF",
        "terms": [
            "BRAF",
            "B-raf",
            "B-RAF1",
            "BRAF1",
            "NS7",
            "RAFB1"
        ]
    },
    "variant": "A712T",
    "createDate": "08/01/2016",
    "updateDate": "09/09/2018",
    "referenceTranscriptCoordinates": {
        "id": 109043,
        "transcript": "NM_004333",
        "gDna": "chr7:g.140734764C>T",
        "cDna": "c.2134G>A",
        "protein": "p.A712T",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10684,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MYC positive colorectal cancer cells harboring BRAF A712T demonstrated increased sensitivity to SCH772984 when treatment was combined with JQ1 in culture, resulting in decreased cell viability (PMID: 27678457).",
            "molecularProfile": {
                "id": 27728,
                "profileName": "BRAF A712T MYC pos"
            },
            "therapy": {
                "id": 5584,
                "therapyName": "JQ1 + SCH772984",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8742,
                    "pubMedId": 27678457,
                    "title": "The MAPK Pathway Regulates Intrinsic Resistance to BET Inhibitors in Colorectal Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27678457"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10686,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MYC positive colorectal cancer cells harboring BRAF A712T demonstrated increased sensitivity to SCH772984 when treatment was combined with JQ1 in culture, resulting in decreased cell viability (PMID: 27678457).",
            "molecularProfile": {
                "id": 27728,
                "profileName": "BRAF A712T MYC pos"
            },
            "therapy": {
                "id": 5585,
                "therapyName": "GSK525762 + Selumetinib",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8742,
                    "pubMedId": 27678457,
                    "title": "The MAPK Pathway Regulates Intrinsic Resistance to BET Inhibitors in Colorectal Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27678457"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 25791,
            "profileName": "BRAF A712T",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 27728,
            "profileName": "BRAF A712T MYC pos",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 109043,
            "transcript": "NM_004333",
            "gDna": "chr7:g.140734764C>T",
            "cDna": "c.2134G>A",
            "protein": "p.A712T",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 109042,
            "transcript": "XM_005250045",
            "gDna": "chr7:g.140734764C>T",
            "cDna": "c.2134G>A",
            "protein": "p.A712T",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}